Table 1.
Comparison of clinical pathological features between patients with CAD and healthy subjects.
| Feature | Patients with CAD (n=102) | Healthy subjects (n=89) | P |
|---|---|---|---|
| Age | 61.2 ± 12.3 | 62.5 ± 9.8 | 0.320 |
| Male, n (%) | 66 (64.7) | 49 (55.1) | 0.174 (x2 = 1.847) |
| Female, n (%) | 36 (35.3) | 40 (44.9) | |
| Hypertension | 82 | 32 | 0.001 (x2 = 39.005) |
| Smoking | 59 | 46 | 0.394 (x2 = 0.728) |
| Diabetes | 68 | 41 | 0.004 (x2 = 8.232) |
| HbA1C (%) | 7.10 ± 0.32 | 5.35 ± 0.78 | 0.152 |
| TG (mmol/L) | 1.79 ± 1.30 | 1.42 ± 0.48 | 0.161 |
| TC (mmol/L) | 4.21 ± 0.34 | 4.42 ± 0.43 | 0.582 |
| LDL-C (mmol/L) | 2.32 ± 0.31 | 2.28 ± 0.36 | 0.290 |
| HDL-C (mmol/L) | 1.19 ± 0.42 | 1.99 ± 0.26 | 0.015 |
| hs-CRP (mg/L) | 4.59 ± 0.18 | 3.82 ± 0.52 | 0.290 |
| Lp (a) (mg/L) | 280.1 ± 103.4 | 254.2 ± 102.6 | 0.210 |
HbA1c: glycosylated hemoglobin A1c; TG: triglyceride; TC: total cholesterol; LDL-C: low-density lipoprotein-cholesterol; hs-CRP: high-sensitivity C-reactive protein; Lp (a): lipoprotein a; HDL-C: high-density lipoprotein-cholesterol.